Tuesday, May 5, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Innovations & Investing

Cyber Risk Is Now a Core Procurement Metric — Expanded Analysis

Cybersecurity risk in healthcare has shifted from a technical concern to a core operational and procurement variable

DAILY REMEDY by DAILY REMEDY
February 4, 2026
in Innovations & Investing
0

Cybersecurity risk in healthcare has shifted from a technical concern to a core operational and procurement variable. Health system leaders increasingly treat cyber disruption not as a low-probability event but as a modeled operational scenario. This shift is changing how technology vendors are evaluated, how architectures are designed, and how purchasing decisions are scored. Cyber resilience is now assessed alongside clinical functionality and financial return.

Healthcare cybersecurity incidents are no longer rare shocks. Ransomware events, vendor compromises, credential breaches, and data integrity attacks occur with sufficient frequency that executive teams plan for them explicitly. Scenario modeling is replacing assumption-based prevention. Boards and executive committees increasingly ask not only how breaches are prevented, but how operations continue when prevention fails.

Scenario planning is replacing checklist security as the dominant evaluation model. Traditional vendor security reviews emphasized control checklists: encryption standards, access controls, and compliance certifications. Current reviews increasingly include scenario exercises. Vendors may be asked how their systems behave under network isolation, credential compromise, or upstream vendor breach. Behavior under stress is evaluated alongside preventive controls.

Downtime tolerance is being quantified at the system level. Committees define maximum tolerable downtime for different categories of technology: mission-critical clinical systems, operational support systems, and analytic tools. Vendors are required to map their products to these tolerance tiers. Higher-tier systems face stricter resilience and recovery expectations. Availability is graded rather than assumed.

Architectural resilience features are gaining weight in procurement scoring. Offline modes, read-only fallbacks, local caching, and rapid restore capabilities are evaluated explicitly. Redundancy design is discussed in vendor reviews. Systems that degrade gracefully receive higher resilience scores than systems that fail completely. Recovery posture is now considered part of security posture.

Supply chain exposure has become visible at the executive level. Software supply chain risk includes third-party libraries, cloud service dependencies, and subcontracted development components. Vendor dependency mapping is increasingly requested. Organizations want to understand concentration risk — whether multiple critical systems depend on the same upstream provider. Opaque dependency stacks trigger extended review.

Transparency reduces perceived fragility. Vendors that provide software bills of materials, dependency disclosures, and patch cadence documentation move through review processes more quickly. Disclosure discipline is becoming a competitive differentiator. Security maturity is partly measured by reporting transparency.

Cyber insurance is shaping architecture decisions. Insurance carriers increasingly impose technical control requirements as coverage conditions. Logging standards, segmentation requirements, backup practices, and authentication controls may be mandated by underwriting criteria. Vendors must align product design with insured control frameworks. Insurance requirements become design constraints.

Procurement processes now integrate cybersecurity review earlier in evaluation. Security review is no longer a late-stage checkpoint after functional approval. In many organizations, vendors cannot advance without preliminary security clearance. This parallel evaluation model lengthens early review but reduces late-stage rejection risk.

Second-order effects are visible in product development velocity. Security-driven architecture can slow feature release cycles because additional controls, testing, and validation are required. However, slower release cadence may improve adoption probability because risk tolerance is low among buyers. The safest tool may ship slower but sell faster. Risk tolerance shapes technical priorities.

Vendor incident response capability is now evaluated as a product attribute. Procurement teams examine breach notification timelines, customer communication protocols, and incident support structures. Response choreography is assessed alongside detection capability. Institutions want evidence that vendors can coordinate effectively during crisis events.

For clinicians, the operational implication is that cyber resilience affects clinical continuity. Technology selection influences downtime frequency and recovery speed. Systems chosen for resilience reduce clinical disruption during incidents. Cybersecurity is therefore indirectly a patient safety factor.

For physician leaders, participation in procurement discussions increasingly includes resilience considerations. Clinical leaders may be asked to define acceptable downtime thresholds and workflow fallback requirements. Clinical input shapes resilience scoring because clinical tolerance varies by function.

Cyber risk has moved from the information technology department to the executive and board level. Procurement frameworks now treat cyber resilience as a primary evaluation dimension. Technology architecture is being shaped by modeled disruption scenarios rather than only by feature roadmaps.

Cybersecurity is no longer only about breach prevention. It is about operational continuity under breach conditions. Procurement decisions reflect this broader framing. Cyber risk is now a standing procurement variable, not an episodic concern.

ShareTweet
DAILY REMEDY

DAILY REMEDY

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Detecting Hospital M&A Synergies Before They’re Announced: A Rate-Based Event Strategy

    Detecting Hospital M&A Synergies Before They’re Announced: A Rate-Based Event Strategy

    0 shares
    Share 0 Tweet 0
  • A Two Headed Monster – State Attorneys General and the Drug Enforcement Agency

    3 shares
    Share 0 Tweet 0
  • The ASC Rate Arbitrage: How Ambulatory Surgery Center Growth Looks in Procedure-Level Price Data

    0 shares
    Share 0 Tweet 0
  • Conspiracy to Convict the Innocent

    0 shares
    Share 0 Tweet 0
  • Nonlinear Healthcare Models

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy